Mitch Collett
Stock Analyst at Deutsche Bank
(1.41)
# 3,415
Out of 4,944 analysts
16
Total ratings
58.33%
Success rate
-5.56%
Average return
Main Sectors:
Stocks Rated by Mitch Collett
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CCEP Coca-Cola Europacific Partners | Maintains: Buy | $78 → $90 | $91.95 | -2.12% | 6 | Sep 9, 2024 | |
| KPTI Karyopharm Therapeutics | Maintains: Outperform | $120 → $75 | $4.45 | +1,585.39% | 2 | Aug 7, 2024 | |
| BUD Anheuser-Busch InBev | Upgrades: Buy | n/a | $61.14 | - | 1 | Jun 22, 2023 | |
| DEO Diageo | Downgrades: Sell | n/a | $110.97 | - | 5 | Jun 29, 2022 | |
| UL Unilever | Downgrades: Hold | n/a | $62.44 | - | 2 | Sep 16, 2021 |
Coca-Cola Europacific Partners
Sep 9, 2024
Maintains: Buy
Price Target: $78 → $90
Current: $91.95
Upside: -2.12%
Karyopharm Therapeutics
Aug 7, 2024
Maintains: Outperform
Price Target: $120 → $75
Current: $4.45
Upside: +1,585.39%
Anheuser-Busch InBev
Jun 22, 2023
Upgrades: Buy
Price Target: n/a
Current: $61.14
Upside: -
Diageo
Jun 29, 2022
Downgrades: Sell
Price Target: n/a
Current: $110.97
Upside: -
Unilever
Sep 16, 2021
Downgrades: Hold
Price Target: n/a
Current: $62.44
Upside: -